Last reviewed 2026-04-20 · How we verify

Lortab

Ulthera, Inc · FDA-approved active Small molecule

At a glance

Generic name	Lortab
Sponsor	Ulthera, Inc
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction (PHASE2, PHASE3)
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery (NA)
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology (NA)
A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery (NA)
The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery (NA)
Post-operative Pain Management in Children With Supracondylar Humerus Fractures (PHASE4)
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery (PHASE4)
SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results